Northpointe Capital’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
GIP
FPC
Northpointe Capital's NEO Position: Q1 2018 in Review
Northpointe Capital sold out of NeoGenomics (NEO) in Q1 2018, closing a stake of 326,553 shares — an estimated $2.89M sold.
Northpointe Capital first reported a position in NEO in Q4 2013 and held it in 17 quarters. The position peaked at $9.37M in Q3 2014. 137 funds tracked by Wall St. Rank hold NEO as of Q1 2018.
- Northpointe Capital reported no remaining NeoGenomics position as of Q1 2018 after selling out during the quarter.
- Northpointe Capital sold 326,553 NeoGenomics shares in Q1 2018, an estimated $2.89M.
- Northpointe Capital first reported a position in NeoGenomics in Q4 2013 and held it in 17 quarters.
- Northpointe Capital's NeoGenomics position peaked at $9.37M in Q3 2014.
- 137 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2018.
Based on Northpointe Capital's 13F filing for Q1 2018, filed 11 Apr 2018.